2013
Resultado de búsqueda
Hace 3 días · Anne Wojcicki. Thank you, Joe. Fiscal 2024 was a productive yet transitional year at 23andMe. The conclusion in July of the exclusive period of our discovery and development collaboration ...
Hace 4 días · On April 18, 2024 the Company announced it has been made aware that Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, is considering making a...
Hace 4 días · “The Company had a productive fourth quarter and solid end to the year, continuing to add value for members of 23andMe+ and advancing our clinical stage assets,” said Anne Wojcicki, Co-Founder & CEO of 23andMe. “We continue to work to build value for customers and shareholders and are looking forward to a transformative FY2025.”
Hace 3 días · Anne Wojcicki destacó la integración de Lemonaid para crear un servicio integral de prevención del bienestar. Se centra en aprovechar la amplia base de datos genéticos para aplicaciones ...
Hace 3 días · 23andMe Holding Co. (ME) disclosed a strategic review to enhance shareholder value and a potential acquisition offer from CEO Anne Wojcicki during its Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results Conference Call. The company reported a revenue downturn due to the end of a key collaboration and lower consumer services sales ...
Hace 3 días · Joining us on our call today are Anne Wojcicki, our Chief Executive Officer and Co-Founder; and Joe Selsavage, our Chief Financial and Accounting Officer; Jennifer Low, our Head of Therapeutics...
Hace 3 días · Published 05/24/2024, 08:05 AM. 0. ME. -. 23andMe Holding Co. (ME) disclosed a strategic review to enhance shareholder value and a potential acquisition offer from CEO Anne Wojcicki during its ...
